42 results on '"Denis, Cécile V."'
Search Results
2. A small-molecule hemostatic agent for the reversal of direct oral anticoagulant–induced bleeding
3. Impact of allele-selective silencing of von Willebrand factor in mice based on a single nucleotide allelic difference in von Willebrand factor
4. Development of a dual hybrid AAV vector for endothelial-targeted expression of von Willebrand factor
5. Type 2N von Willebrand disease: genotype drives different bleeding phenotypes and treatment needs
6. How unique structural adaptations support and coordinate the complex function of von Willebrand factor
7. Angiopoietin-2 binds to multiple interactive sites within von Willebrand factor
8. Transplacental delivery of therapeutic proteins by engineered immunoglobulin G: a step toward perinatal replacement therapy
9. Efficacy of platelet-inspired hemostatic nanoparticles on bleeding in von Willebrand disease murine models
10. A nanobody against the VWF A3 domain detects ADAMTS13-induced proteolysis in congenital and acquired VWD
11. ADP receptor P2Y12 is the capstone of the cross-talk between Ca2+ mobilization pathways dependent on Ca2+ ATPases sarcoplasmic/endoplasmic reticulum type 3 and type 2b in platelets
12. Thrombin generation on vascular cells in the presence of factor VIII and/or emicizumab
13. A gain‐of‐function filamin A mutation in mouse platelets induces thrombus instability
14. Antithrombotic potential of a single‐domain antibody enhancing the activated protein C‐cofactor activity of protein S
15. New insights into regulation of αIIbβ3 integrin signaling by filamin A
16. The Role of Platelets and von Willebrand Factor in the Procoagulant Phenotype of Inflammatory Bowel Disease.
17. Differences in venous clot structures between hemophilic mice treated with emicizumab versus factor VIII or factor VIIIFc
18. The role of platelets and von Willebrand factor in the procoagulant phenotype of inflammatory bowel disease
19. MAGT1 deficiency in XMEN disease is associated with severe platelet dysfunction and impaired platelet glycoprotein N-glycosylation
20. Shear Forces Induced Platelet Clearance Is a New Mechanism of Thrombocytopenia
21. IdeS, a new option to optimize the management of patients with hemophilia A on emicizumab
22. Modèles murins en hémostase.
23. Von Willebrand factor and cancer: Another piece of the puzzle
24. N-Glycosylation Deficiency Reduces the Activation of Protein C and Disrupts Endothelial Barrier Integrity
25. Identification of von Willebrand factor D4 domain mutations in patients of Afro‐Caribbean descent: In vitro characterization
26. TaSER: Combining forces to stop the clot
27. How to keep the factor VIII/von Willebrand factor complex in the circulation
28. The Proteolytic Inactivation of Protein Z-Dependent Protease Inhibitor by Neutrophil Elastase Might Promote the Procoagulant Activity of Neutrophil Extracellular Traps in Sepsis.
29. VWF/LRP4/αVβ3-axis represents a novel pathway regulating proliferation of human vascular smooth muscle cells.
30. A compact integrated microfluidic oxygenator with high gas exchange efficiency and compatibility for long-lasting endothelialization.
31. Thrombin generation on vascular cells in the presence of factor VIII and/or emicizumab
32. Von Willebrand factor: how unique structural adaptations support and coordinate its complex function
33. Unique humanized mouse models of von Willebrand disease type 2A.
34. A nanobody against the von Willebrand factor A3 domain detects ADAMTS13-induced proteolysis in congenital and acquired von Willebrand disease
35. An Inhibitory Single-Domain Antibody against Protein Z-Dependent Protease Inhibitor Promotes Thrombin Generation in Severe Hemophilia A and FXI Deficiency.
36. von Willebrand disease.
37. Implications of von Willebrand Factor in Inflammatory Bowel Diseases: Beyond Bleeding and Thrombosis.
38. Differences in venous clot structures between hemophilic mice treated with emicizumab versus factor VIII or factor VIIIFc.
39. ADP receptor P2Y12 is the capstone of the cross-talk between Ca 2+ mobilization pathways dependent on Ca 2+ ATPases sarcoplasmic/endoplasmic reticulum type 3 and type 2b in platelets.
40. How to keep the factor VIII/von Willebrand factor complex in the circulation.
41. Gain-of-Function Variant p.Pro2555Arg of von Willebrand Factor Increases Aggregate Size through Altering Stem Dynamics.
42. The VWF/LRP4/αVβ3-axis represents a novel pathway regulating proliferation of human vascular smooth muscle cells.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.